{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:49:52Z","timestamp":1790174992548,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00125-021-05396-5","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T01:58:18Z","timestamp":1612835898000},"page":"1059-1065","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Transforming type 1 diabetes: the next wave of innovation"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6688-8127","authenticated-orcid":false,"given":"Daniel J.","family":"Drucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,6]]},"reference":[{"issue":"4","key":"5396_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s00125-019-05080-9","volume":"63","author":"A Philis-Tsimikas","year":"2020","unstructured":"Philis-Tsimikas A, Klonoff DC, Khunti K et al (2020) Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial. Diabetologia 63(4):698\u2013710. https:\/\/doi.org\/10.1007\/s00125-019-05080-9","journal-title":"Diabetologia"},{"issue":"22","key":"5396_CR2","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1056\/NEJMoa2022474","volume":"383","author":"J Rosenstock","year":"2020","unstructured":"Rosenstock J, Bajaj HS, Janez A et al (2020) Once-weekly insulin for type 2 diabetes without previous insulin treatment. N Engl J Med 383(22):2107\u20132116. https:\/\/doi.org\/10.1056\/NEJMoa2022474","journal-title":"N Engl J Med"},{"issue":"4","key":"5396_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41573-019-0053-0","volume":"19","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ (2020) Advances in oral peptide therapeutics. Nat Rev Drug Discov 19(4):277\u2013289. https:\/\/doi.org\/10.1038\/s41573-019-0053-0","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"5396_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S2213-8587(18)30372-3","volume":"7","author":"IB Halberg","year":"2019","unstructured":"Halberg IB, Lyby K, Wassermann K, Heise T, Zijlstra E, Plum-Morschel L (2019) Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial. Lancet Diabetes Endocrinol 7(3):179\u2013188. https:\/\/doi.org\/10.1016\/S2213-8587(18)30372-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"5396_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/dme.14202","volume":"37","author":"ER Seaquist","year":"2020","unstructured":"Seaquist ER, Blonde L, McGill JB et al (2020) Hypoglycaemia is reduced with use of inhaled Technosphere\u00ae insulin relative to insulin aspart in type 1 diabetes mellitus. Diabet Med 37(5):752\u2013759. https:\/\/doi.org\/10.1111\/dme.14202","journal-title":"Diabet Med"},{"issue":"6427","key":"5396_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1126\/science.aau2277","volume":"363","author":"A Abramson","year":"2019","unstructured":"Abramson A, Caffarel-Salvador E, Khang M et al (2019) An ingestible self-orienting system for oral delivery of macromolecules. Science 363(6427):611\u2013615. https:\/\/doi.org\/10.1126\/science.aau2277","journal-title":"Science"},{"key":"5396_CR7","doi-asserted-by":"crossref","unstructured":"Jarosinski MA, Dhayalan B, Rege N, Chatterjee D, Weiss MA (2021) \u2018Smart\u2019 insulin delivery technologies and intrinsic glucose-responsive analogues. Diabetologia (in press)","DOI":"10.1007\/s00125-021-05422-6"},{"key":"5396_CR8","doi-asserted-by":"publisher","unstructured":"Boughton CK, Hovorka R (2021) New closed-loop insulin systems. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-021-05391-w","DOI":"10.1007\/s00125-021-05391-w"},{"key":"5396_CR9","doi-asserted-by":"publisher","unstructured":"Nathan DM (2021) Realising the long-term promise of insulin therapy: the DCCT\/EDIC study. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-021-05397-4","DOI":"10.1007\/s00125-021-05397-4"},{"key":"5396_CR10","doi-asserted-by":"publisher","unstructured":"Amiel SA (2021) The consequences of hypoglycaemia. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-020-05366-3","DOI":"10.1007\/s00125-020-05366-3"},{"issue":"11","key":"5396_CR11","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.2337\/db10-0676","volume":"59","author":"HA Keenan","year":"2010","unstructured":"Keenan HA, Sun JK, Levine J et al (2010) Residual insulin production and pancreatic ss-cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 59(11):2846\u20132853. https:\/\/doi.org\/10.2337\/db10-0676","journal-title":"Diabetes"},{"issue":"53","key":"5396_CR12","doi-asserted-by":"publisher","first-page":"eaaw9996","DOI":"10.1126\/scitranslmed.aaw9996","volume":"12","author":"C Ackeifi","year":"2020","unstructured":"Ackeifi C, Wang P, Karakose E et al (2020) GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human beta cell regeneration. Sci Transl Med 12(53):eaaw9996. https:\/\/doi.org\/10.1126\/scitranslmed.aaw9996","journal-title":"Sci Transl Med"},{"key":"5396_CR13","doi-asserted-by":"publisher","unstructured":"Melton D (2021) The promise of stem cell-derived islet replacement therapy. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-020-05367-2","DOI":"10.1007\/s00125-020-05367-2"},{"issue":"4","key":"5396_CR14","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.stem.2020.09.008","volume":"27","author":"JA Bluestone","year":"2020","unstructured":"Bluestone JA, Tang Q (2020) Solving the puzzle of immune tolerance for beta-cell replacement therapy for type 1 diabetes. Cell Stem Cell 27(4):505\u2013507. https:\/\/doi.org\/10.1016\/j.stem.2020.09.008","journal-title":"Cell Stem Cell"},{"issue":"7733","key":"5396_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-018-0733-7","volume":"563","author":"Q Liang","year":"2018","unstructured":"Liang Q, Monetti C, Shutova MV et al (2018) Linking a cell-division gene and a suicide gene to define and improve cell therapy safety. Nature 563(7733):701\u2013704. https:\/\/doi.org\/10.1038\/s41586-018-0733-7","journal-title":"Nature"},{"key":"5396_CR16","doi-asserted-by":"publisher","unstructured":"McLean BA, Wong CK, Campbell JE, Hodson DJ, Trapp S, Drucker DJ (2020) Revisiting the complexity of GLP-1 action-from sites of synthesis to receptor activation. Endocr Rev. https:\/\/doi.org\/10.1002\/dev.22079","DOI":"10.1002\/dev.22079"},{"issue":"12","key":"5396_CR17","doi-asserted-by":"publisher","first-page":"e4638","DOI":"10.1210\/clinem\/dgaa624","volume":"105","author":"PM Pollanen","year":"2020","unstructured":"Pollanen PM, Ryhanen SJ, Toppari J et al (2020) Dynamics of islet autoantibodies during prospective follow-up from birth to age 15 years. J Clin Endocrinol Metab 105(12):e4638\u2013e4651. https:\/\/doi.org\/10.1210\/clinem\/dgaa624","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"5396_CR18","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.2337\/dc20-0701","volume":"43","author":"HM Ismail","year":"2020","unstructured":"Ismail HM, Cleves MA, Xu P et al (2020) The pathological evolution of glucose response curves during the progression to type 1 diabetes in the TrialNet Pathway to Prevention study. Diabetes Care 43(11):2668\u20132674. https:\/\/doi.org\/10.2337\/dc20-0701","journal-title":"Diabetes Care"},{"issue":"8","key":"5396_CR19","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","volume":"26","author":"LA Ferrat","year":"2020","unstructured":"Ferrat LA, Vehik K, Sharp SA et al (2020) A combined risk score enhances prediction of type 1 diabetes among susceptible children. Nat Med 26(8):1247\u20131255. https:\/\/doi.org\/10.1038\/s41591-020-0930-4","journal-title":"Nat Med"},{"issue":"7","key":"5396_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold KC, Bundy BN, Long SA et al (2019) An anti-CD3 antibody, Teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 381(7):603\u2013613. https:\/\/doi.org\/10.1056\/NEJMoa1902226","journal-title":"N Engl J Med"},{"issue":"21","key":"5396_CR21","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1056\/NEJMoa2006136","volume":"383","author":"T Quattrin","year":"2020","unstructured":"Quattrin T, Haller MJ, Steck AK et al (2020) Golimumab and Beta-cell function in youth with new-onset type 1 diabetes. N Engl J Med 383(21):2007\u20132017. https:\/\/doi.org\/10.1056\/NEJMoa2006136","journal-title":"N Engl J Med"},{"key":"5396_CR22","doi-asserted-by":"publisher","unstructured":"Marfil-Garza BA, Hefler J, Bermudez De Leon M, Pawlick R, Dadheech N, Shapiro AMJ (2020) Progress in translational regulatory T cell therapies for type 1 diabetes and islet transplantation. Endocr Rev. https:\/\/doi.org\/10.1210\/endrev\/bnaa028","DOI":"10.1210\/endrev\/bnaa028"},{"key":"5396_CR23","doi-asserted-by":"publisher","unstructured":"Beran D, Lazo-Porras M, Mba CM, Mbanya JC (2021) A global perspective on the issue of access to insulin. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-020-05375-2","DOI":"10.1007\/s00125-020-05375-2"},{"key":"5396_CR24","doi-asserted-by":"publisher","unstructured":"Chan JCN, Lim LL, Wareham NJ et al (2020) The Lancet commission on diabetes: using data to transform diabetes care and patient lives. Lancet 396(10267):2019\u20132082. https:\/\/doi.org\/10.1016\/S0140-6736(20)32374-6","DOI":"10.1016\/S0140-6736(20)32374-6"},{"key":"5396_CR25","unstructured":"World Health Organization (2020). The WHO Global Diabetes Compact: uniting around a common agenda for diabetes. Available from: www.who.int\/docs\/default-source\/world-diabetes-day\/global-diabetes-compact-final.pdf Accessed 13 January 2021"},{"key":"5396_CR26","unstructured":"Banting FG (1925) Frederick G. Banting Nobel Lecture. Available from: www.nobelprize.org\/prizes\/medicine\/1923\/banting\/lecture\/. Accessed: 13 January 2021"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05396-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05396-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T01:02:22Z","timestamp":1644109342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05396-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,6]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["5396"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05396-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,6]]},"assertion":[{"value":"1 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}